Refactory angina and coronary sinus reducer, from established applications to future outlooks

Supported by Shockwave Medical

Summary

In this discussion, Tim van de Hoef and Tommaso Gori explore the evolving definition of refractory angina, extending beyond obstructive disease to include non-obstructive and microvascular conditions. They highlight the challenges of recognition, driven by variability in symptoms, diagnostic approaches, and clinical practices, and stress that “refractory” should not be seen as a hopeless condition. With emerging evidence-based options, notably the balloon-expandable coronary sinus reducer, new treatment avenues are opening for these patients.

This interview was filmed at EuroPCR 2026: see more videos here.